MiR-181b is a biomarker of disease progression in Chronic Lymphocytic Leukemia

ABSTRACT: We studied the value of the microRNAs as a signature for Chronic lymphocytic leukemia (CLL) patients with specific chromosomal abnormalities. We found that MiR-181b is abiomarker of disease progression in Chronic Lymphocytic Leukemia

ORGANISM(S): Homo sapiens

SUBMITTER: Rosa Visone 

PROVIDER: E-MTAB-683 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress